FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example CodeSystem/allergy-intolerance-type (JSON)

Patient Care Work GroupMaturity Level: N/AStandards Status: Informative

Raw JSON (canonical form + also see JSON Format Specification)

Definition for Code SystemAllergyIntoleranceType

{
  "resourceType" : "CodeSystem",
  "id" : "allergy-intolerance-type",
  "meta" : {
    "lastUpdated" : "2024-11-07T14:43:37.879+00:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem allergy-intolerance-type</b></p><a name=\"allergy-intolerance-type\"> </a><a name=\"hcallergy-intolerance-type\"> </a><a name=\"allergy-intolerance-type-en-US\"> </a><p>This case-sensitive code system <code>http://hl7.org/fhir/allergy-intolerance-type</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">allergy<a name=\"allergy-intolerance-type-allergy\"> </a></td><td>Allergy</td><td>A propensity for hypersensitive reaction(s) to a substance.  These reactions are most typically type I hypersensitivity, plus other &quot;allergy-like&quot; reactions, including pseudoallergy.</td></tr><tr><td style=\"white-space:nowrap\">intolerance<a name=\"allergy-intolerance-type-intolerance\"> </a></td><td>Intolerance</td><td>A propensity for adverse reactions to a substance that is judged to be not allergic or &quot;allergy-like&quot;.  These reactions are typically (but not necessarily) non-immune.  They are to some degree idiosyncratic and/or patient-specific (i.e. are not a reaction that is expected to occur with most or all patients given similar circumstances).</td></tr></table></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
    "valueCode" : "pc"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
    "valueCode" : "trial-use"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
    "valueInteger" : 3
  }],
  "url" : "http://hl7.org/fhir/allergy-intolerance-type",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.4.132"
  },
  {
    "use" : "old",
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.1.122"
  },
  {
    "use" : "old",
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.2.52"
  }],
  "version" : "6.0.0-ballot2",
  "name" : "AllergyIntoleranceType",
  "title" : "Allergy Intolerance Type",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-01-05T10:01:24+11:00",
  "publisher" : "HL7 (FHIR Project)",
  "contact" : [{
    "telecom" : [{
      "system" : "url",
      "value" : "http://hl7.org/fhir"
    },
    {
      "system" : "email",
      "value" : "fhir@lists.hl7.org"
    }]
  }],
  "description" : "Identification of the underlying physiological mechanism for a Reaction Risk.",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
      "code" : "001",
      "display" : "World"
    }]
  }],
  "caseSensitive" : true,
  "valueSet" : "http://hl7.org/fhir/ValueSet/allergy-intolerance-type",
  "content" : "complete",
  "concept" : [{
    "code" : "allergy",
    "display" : "Allergy",
    "definition" : "A propensity for hypersensitive reaction(s) to a substance.  These reactions are most typically type I hypersensitivity, plus other \"allergy-like\" reactions, including pseudoallergy."
  },
  {
    "code" : "intolerance",
    "display" : "Intolerance",
    "definition" : "A propensity for adverse reactions to a substance that is judged to be not allergic or \"allergy-like\".  These reactions are typically (but not necessarily) non-immune.  They are to some degree idiosyncratic and/or patient-specific (i.e. are not a reaction that is expected to occur with most or all patients given similar circumstances)."
  }]
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.